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Background: The diagnosis of cutaneous leishmaniasis (CL) might be difficult, in particular in endemic areas where
different species of Leishmania can cause lesions of very similar appearance and where other skin diseases with
similar clinical symptoms occur. Even today, the parasitological diagnosis of CL remains the gold standard and it is
based on the direct identification of amastigotes in microscopy smears and/or culture of promastigotes from
infected tissues. Although these techniques are highly specific, they are not sensitive enough. The objective of this
study is to contribute to improving the diagnosis of CL and the identification of Leishmania species in Morocco by
comparing three PCR-based assays applied directly on dermal samples.
Methods: A total of 58 patients presenting with cutaneous lesions suggestive of CL were sampled for parasitological
diagnosis by direct examination (DE), culture in NNN medium, two kinetoplast DNA (kDNA) PCRs (Lmj4/Uni21 and
13A/13B primers) and one rRNA gene internal transcribed spacer 1 (ITS1) PCR (LITSR/L5.8S primers). The techniques
were statistically analyzed and compared.
Results: According to our consensus positive, 44 out of 58 samples were true positives. The 13A/13B-PCR and ITS1-PCR
showed the highest sensitivities (100%). Parasite microscopy and culture detected 43% and 29% of the true positives,
respectively, while culture and microscopy together improved sensitivity to 52%. PCRs 13A/13B and ITS1 were associated
to four and one false positives, respectively, while the other assays were 100% specific. Furthermore, the ITS1-PCR-RFLP
assay clearly identified the Leishmania species for all the true positives (44/44), whereas Lmj4/Uni21-PCR identified 35/44
samples. The comparison between the Leishmania molecular characterizations and the expected species according to
the national data from the Ministry of Health indicate 7 discrepant results.
Conclusions: The PCR-based assays tested on our samples increased the speed and sensitivity of the diagnosis of CL
compared to the conventional techniques. Furthermore, we showed that we can not base the species identification
on the national data from the Ministry of Health. Finally, we suggest the use of PCR-ITS1-RFLP for diagnosis and
simultaneous identification of the species in the Moroccan epidemiological context, but also in similar areas of
the Mediterranean Basin.
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Leishmaniases are vector-borne parasitic diseases caused
by protozoa of the genus Leishmania (Kinetoplastida:
Trypanosomatidae) [1]. The clinical spectrum of these
diseases range from self-resolving cutaneous lesions to
visceral forms, fatal if left untreated.
Leishmaniases remain one of the world’s most devas-
tating neglected tropical diseases.
According to the World Health Organization (WHO),
up to 350 million people are at risk in 98 countries
around the world. It is considered that approximately
12 million people are currently infected, and 2 million
new infections occur every year, of which an esti-
mated 1.5 million cases are cutaneous [2,3]. Cutane-
ous leishmaniasis (CL) occurs either as zoonotic or
anthroponotic infections, commonly caused by various
species of Leishmania, namely Leishmania major,
L. tropica, L. infantum, L. aethiopica, L. mexicana,
L. amazonensis, or L. braziliensis [4]. They cause skin
ulcers on the exposed parts of the body and scars can
cause serious social prejudice [5].
The diagnosis of CL can be difficult, especially in
endemic areas where different species of Leishmania
can cause lesions of very similar appearance and where
other skin diseases with similar clinical symptoms occur.
This may impair or prevent the proper course of treat-
ment: for instance CL caused by viscerotropic species
(e.g. L. infantum) may need an appropriate therapeutic
monitoring [6].
Presumptive diagnosis of CL is based on clinical symp-
toms. Even today, the parasitological diagnosis remains
the gold standard and it is based on the direct identifica-
tion of amastigotes in microscopy smears and/or culture
of promastigotes from infected tissues [7]. Although
these techniques are highly specific, they are not sensi-
tive enough and are generally time-consuming [8]. In
addition, culture should be kept for at least one month
before definitive negative result [9]. When promastigotes
are isolated, additional techniques must be used for spe-
cies characterization: multilocus enzyme electrophoresis
analysis remains the current gold standard, but it re-
quires mass culturing of the parasites [10].
In Morocco, CL still remains a major public health
problem caused by three Leishmania species. L. major is
the causative agent of zoonotic CL characterized by suc-
cessive endemic and epidemic cycles in arid presaharian
areas of the country [11]. L. tropica is the causative
agent of anthroponotic CL which is hypoendemic in
rural areas of central Morocco and expanded to northern
areas in the 1990s; currently it is not only characterized by
the widest geographical distribution in Morocco but also
in North Africa with the highest incidence rate [12,13].
Finally, the viscerotropic species L. infantum is also
involved in sporadic CL in the northern areas of VLdistribution; the first case was documented in 1996 in a
Northern active focus of Canine leishmaniasis in the Rif
Mountains and recently a new L. infantum CL focus (Sidi
Kacem) was also identified in the North [13-15].
Even today, the diagnosis of CL in Morocco is mainly
based on clinical symptoms and microscopic examin-
ation of smears; culture is carried out only in some spe-
cialized laboratories. Furthermore, the national data on
the geographical distribution of Leishmania species to-
gether with the clinical presentation of the resulting
disease are frequently used for species identification.
However, the increased clinical diversity and the geo-
graphical extension of L. tropica beyond the areas where
it was previously recorded, make these criteria inad-
equate for species identification [16]. Thus, the diversity
of the species associated with human CL and the chan-
ging epidemiological situation in Morocco highlights the
need for the development of a method allowing the diag-
nosis and the characterization of the infective species:
this method has to be preferably simple, cheap, and less
time consuming than the gold standard. In this frame,
PCR-based methods offer an alternative approach to
traditional techniques [17]. A crude search in the Pub-
Med database revealed that since 1989, more than 700
articles on PCR diagnosis of leishmaniases have been
published, in which a multitude of gene targets, proto-
cols, and applications are described, including genus
and/or species-specific PCR, ranging from low-tech
to high-tech approaches [7]. The PCR-based assays cur-
rently constitute the main molecular diagnostic approach
for the detection and identification of Leishmania para-
sites in clinical samples [7]. PCR primers targeting the
kinetoplast and ribosomal DNA genes are amongst the
most commonly used for the diagnosis and/or identifica-
tion of Leishmania species in the Old World and they
provide good results [17-22]. For our purpose and ac-
cording to the literature, the 13A/13B and Lmj4/Uni21
primers derived from kDNA sequences, and LITSR/
L5.8S primers targeting the internal transcribed spacer-1
of the rDNA appeared to be suitable in our epidemio-
logical context.
Thus, given the diversity of the clinical presentations
and the circulation of three potentially responsible spe-
cies of CL in Morocco, the objective of this study is to
contribute to improving the diagnosis of the disease and
the identification of the causative Leishmania species in
Morocco by comparing three selected PCR-based assays
applied directly on dermal samples.
Methods
Ethics statement
This study was conducted according to the princi-
ples specified in the Declaration of Helsinki and under
the local ethical guidelines (Comité d’Ethique pour la
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Casablanca, Morocco).Patients and samples
Amongst the patients consulting at the Department of
Dermatology - Ibn Rochd Hospital, Casablanca -, 58
presented with cutaneous lesions suggestive of CL; they
were sampled by the dermatologist for parasitological
and molecular diagnosis.
Out of these 58 patients sampled, 23 were men and 35
were women with an average age of 33 ± 24 years:
patients were mostly younger than 12 years and older
than 49 years. The duration of lesion prior to sampling
ranged from 2 weeks to 48 months (Table 1). Further-
more, fifty two patients (52/58) either lived in an en-
demic area of CL or had a history of travel to a known
CL focus, according to the Ministry of Health data based
on cases reported by the clinicians and epidemiological
case detection studies.
The dermal syringe-sucked fluid was collected under
sterile conditions from the border of active skin lesions
from each patient as follows: the lesions were cleaned
with alcohol, and 0.1 to 0.2 ml of sterile saline solution
was injected using a syringe (1-ml, 25-gauge needle) into
the nodule and the needle was rotated gently several
times. A small amount of saline solution was injected
into the tissue, and then aspirated. Three syringes were
used for each patient in order to take samples of the der-
mal fluid for culture, PCR assays, and for microscopy
examination. The sample meant for the PCR was con-
served at −30°C until processing.
An information sheet specifying the age, the sex, and
the place of infection was filled, in order to compare
the species characterization results with the data of the
Ministry of Health.Leishmania strains
Reference strains of L. major (MHOM/IL/81/Friedlin),
L. tropica (MHOM/SU/74/K27) and L. infantum
(MHOM/ES/90/LEM2205) were included: frozen strains
at −80°C were thawed and then cultured in RPMI 1640
medium in order to prepare the DNA from the references
(See corresponding paragraphs).Table 1 Time evolution of skin lesions prior to sampling





Total 58Direct examination (DE)
Syringe-sucked dermal fluid was smeared onto glass
slides, air dried and fixed with absolute methanol,
allowed to dry, and then stained with Giemsa. The whole
slide was analyzed with a 100× immersion objective. All
the slides were inspected for the presence of amastigote
forms at least twice before delivering the final result.
Parasite culture
The syringe-sucked dermal fluid was inoculated in sterile
conditions to NNN medium supplemented with 1% sterile
human urine [23], and then incubated at 24-28°C. The
supernatant was examined for parasite growth by light mi-
croscopy every three days and subcultured once a week for
6 weeks before they were reported as negative. Positive cul-
tures were transferred to RPMI-1640 supplemented with
10% fetal calf serum for mass culturing.
The reference strains were also cultured as described
above after thawing.
DNA isolation
DNA was extracted from each clinical sample (100 μl
volume) preserved at −30°C and from the reference strains
culture (volumes corresponding to 1.106 parasites) using
the Pure Link™ Genomic DNA Mini Kit (Invitrogen, UK)
according to the manufacturer’s instructions. The DNA
was kept at −20°C until PCR processing.
Leishmania serial dilution assay
The lowest detection threshold of each PCR method was
estimated using a serial of dilutions of DNA extracted
from 7-day-old promastigotes cultures of two reference
strains of L. major and L. tropica, which were counted
using a Thoma haemocytometer. They were resuspended
in 200 μl of whole human blood adjusted to 1000 para-
sites and the DNA was extracted. From this DNA, serial
dilutions were made in order to obtain DNA yield
equivalent to 100, 50, 10, 5, 1, 0.5, 0.1, and 0.01 parasites
per PCR tube. The test was repeated twice.
PCR amplification and internal control
The three PCR assays tested are described hereafter
(Table 2):
– The Minicircle kDNA was amplified using two
different sequence pairs of primers: 13A/13B and
Lmj4/Uni21 as described by Reale et al. [24] and
Anders et al. [25] respectively.
– ITS1 PCR assay was carried out as described by
Schönian et al. [26], using the primers LITSR/L5.8S
to amplify the ribosomal ITS1 region.
The PCR conditions were optimized for each assay
by using the DNA from the three reference strains of














13A 5′-GTG GGG GAG GGG CGT TCT-3′ 94°C for 4 min, 94°C for 1 min, 60°C for 1 min,
72°C for 1 min, 72°C for 10 min (30 cycles)
1.5 0.2 1 1 2.5
13B 5′-ATT TTC CAC CAA CCC CCA GTT-3′
Lmj4 5′-CTA GTT TCC C GC CTC CGA G-3′ 94°C for 4 min, 94°C for 1 min, 55°C for 1 min,
72°C for 1 min, 72°C for 10 min (35 cycles)
1.5 0.2 1 1 2.5
Uni21 5′-GGG GTT GGT GTA AAA TAG GCC-3′
LITSR 5′-CTG GAT CAT TTT CCG ATG-3′ 94°C for 4 min, 94°C for 40 sec,53°C for 30 sec,
72°C for 1 min, 72°C for 10 min (40 cycles)
2 0.2 0.5 1.5 10
L5.8S 5′-TGA TAC CAC TTA TCG CAC TT 3′
GH20 5′-GAA GAG CCA AGG ACA GGT AC-3′ 94°C for 4 min, 94°C for 30 sec, 54.5°C for 1 min,
72°C for 1.3 min, 72°C for 10 min (40 cycles)
2.5 0.2 0.4 1 2
PCO4 5′-CAA CTT CAT CCA CGT TCA CC-3′
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volume except for the ITS1 PCR (in 50 μl), and per-
formed in a DNA thermal cycler (Techne Genius Thermal
Cycler, USA).
To avoid DNA contamination, the different steps of the
technical procedures were carried out in separate areas
with dedicated pipette batches and decontamination
procedures according to standard recommendations [27].
The presence of possible PCR reaction inhibitors was
ascertained by testing the samples with negative PCR
results for Leishmania using the specific primers for the
human beta-globin gene GH20/PCO4 as described by
Saiki et al. [28].
A PCR result was considered positive when a band of
the expected size was obtained: ~120 bp for 13A/13B
(Leishmania genus), ~650-800 bp for Lmj4/Uni21
(~650 bp for L. major and ~800 bp for L. tropica/
L. infantum), ~300-350 bp for ITS1 (Leishmania
genus), and ~268 bp for β-globin gene PCR.
After the amplification, PCR products were analyzed
by 1–2.5% agarose gel electrophoresis/ethidium bromide
staining and visualized under UV transilluminator.
RFLP analysis
The ITS1 PCR product was digested with HaeIII enzyme
(Invitrogen, UK) according to the manufacturer’s in-
structions. The restriction fragments were analyzed by
2.5% agarose electrophoresis/ethidium bromide staining:
they were visualized by UV light. The digestion of ITS1
products reveals three bands for L. infantum (200, 100,
and 50 bp), two bands for L. tropica (220 and 50 bp),
and two for L. major (220 and 127 bp).
Statistical analysis
By consensus we considered specimens as true positives
when cultures or stained tissue smears or at least two PCR
assays were positive for Leishmania DNA. Sensitivity,
specificity, positive predictive values (PPV), negative
predictive values (NPV), and Cohen’s kappa coeffi-
cient (χ) were determined. Cohen’s kappa coefficientis a measure of the agreement between two tests be-
yond that expected by chance, where 0 is chance
agreement and 1 is perfect agreement [29,30]. The strength
of agreement is defined as follows: poor (<0.20), fair (0.21-
0.40), moderate (0.41-0.60), good (0.61-0.80), and very
good (0.81-1.00).
The association between different variables was esti-
mated using a binary logistic regression analysis (SPSS
software v 20.0), at a significance level of 5%.
Results
Of the 58 specimens collected from the patients with
suspected CL, and according to our consensus criteria,
44 samples were true positives with a female predomi-
nance (OR = 3.857; IC 95%: 1.090-13.652; p = 0.036) and
14 were true negatives. CL diagnosis was negatively as-
sociated with the duration of lesions prior to sampling
(Odds Ratio = 0.923; Confidence Interval 95%: 0.858-
0.993; p = 0.033). The results obtained with the different
assays are presented in Tables 3 and 4.
Stained tissue smears and parasite culture
Both parasite cultures and DE were highly specific (100%)
for the diagnosis of CL, and when considered together
they correctly identified 23/44 of the true positive speci-
mens, while 14 of these true positives (14/23) were de-
tected only by one of the two methods. Their respective
sensitivities (microscopy: 43%; culture: 29%) were im-
proved when both methods were combined (52%). The
level of agreement, Cohen’s kappa coefficient (χ ± standard
error [SE]), between culture and DE (0.330 ± 0.150) was
fair. Furthermore, the levels of agreement between positive
cultures or DE and the consensus results (true positive
and true negative samples) were respectively 0.170 ± 0.102
(poor) and 0.270 ± 0.110 (fair) - Table 4 - . On the other
hand all the 23 specimens positive by culture and/or DE
were confirmed by at least two of the PCR assays (Table 3).
The DE and culture results have a negative correlation
with the time evolution of skin lesions (OR = 0.861; CI
95%: 0.740-1.001; p = 0. 05).
Table 3 Results of the different diagnostic methods
Direct examination Culture 13A/13B PCR Lmj4/uni21 PCR ITS1 PCR Final interpretation* Number (total: 58)
- - + + + + 16
- - + - + + 5
- - - - + - 1
- - + - - - 4
- - - - - - 9
- + + + + + 4
+ + + + + + 9
+ - + + + + 6
+ - + - + + 4
*According to the consensus positive.
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Serial dilutions of DNA of the reference parasite strains
led to different detection thresholds of each PCR
method: 0.1 parasite cells per PCR tube (p/t) for
13A/13B primers, 1 p/t for LITSR/L5.8S primers, and
5 p/t with Lmj4/Uni21 primers. The results were
reproducible.
Comparison of the PCR assays for CL diagnosis
Amongst the 58 samples, 48 were positive by the 13A/
13B PCR, of which 44 were true positives (Table 4): the
sensitivity and specificity values are 100% and 71% re-
spectively; the PPV and NPV for this assay were 92%
and 100%, respectively. The level of agreement between
the consensus results and the 13A/13B PCR results was
good: 0.791 ± 0.101.
The ITS1 PCR displayed a high sensitivity (100%),
diagnosing 44/44 of the true positives (Table 4). The
PPV and the NPV for the ITS1 assay were 98% and
100% respectively. The level of agreement between the
consensus results and the ITS1 PCR was very good:
0.950 ± 0.040.
The sensitivity of the Lmj4/Uni21 PCR was 79% while
its specificity and the PPV were 100%, since no false
positives were found (Table 4). The NPV of this assay











Direct examination 19 19 39 14
Culture 13 13 45 14
13A/13B PCR 48 44 10 10
Lmj4/Uni21 PCR 35 35 23 14
ITS1-PCR 45 44 13 13
PCR c 44 44 14 14
Total 44 14
PPV: Positive Predictive Value; NPV: Negative Predictive Value; PCRc: PCR consensu
95% CI for sensitivity, specificity, PPV and NPV.Uni21 PCR and the consensus results was also good:
0.652 ± 0.106. The results of the PCR consensus (PCR
consensus were considered positive when at least two
PCR assays were positive) had a negative correlation
with the time evolution of skin lesions (p = 0. 03).
Identification of Leishmania species
Leishmania species identification was carried out using
the ITS1 and Lmj4/Uni21 PCRs. The ITS1 PCR-RFLP
assay clearly identified the species for all the true posi-
tives (44/44) (Figure 1, Table 5), whereas Lmj4/Uni21
PCR identified 35/44 samples; this latter primer did not
allow the differentiation between L. tropica and L.
infantum (Figure 2, Table 5).
No species discrepant results were noted between the
two techniques, however, an additional sample, not con-
sidered as a true positive according to our consensus cri-
teria was characterized as L. infantum by the ITS1 PCR
(Figure 1).
On the other hand, 7 discrepant results were obtained
between the consensus Leishmania diagnosis and the
national data from the Ministry of Health (Table 6).
Detection of PCR inhibition
PCR inhibitors are a setback in clinical samples from dif-
ferent sources. Successful amplification of the beta-s for cutaneous leishmaniasis
Sensitivity (%) Specificity (%) PPV (%) NPV (%) χ ± [SE]
43 100 100 36 0.270 ± 0.110
29 100 100 31 0.170 ± 0.102
100 71 92 100 0.791 ± 0.101
79 100 100 61 0.652 ± 0.106
100 93 98 100 0.950 ± 0.040
100 100 100 100
s results.
Figure 1 2.5% Agarose gel electrophoresis of ITS1-PCR restriction
fragments. Wells: 1 – 10: patient samples; L. m: reference DNA of
L. major; L. t: reference DNA of L. tropica; L. i: reference DNA of
L. infantum; NC: negative control sample (H2O); WM: Weight Marker
(50 bp DNA Ladder; Invitrogen Life Technologies, Brazil).
Mouttaki et al. Parasites & Vectors 2014, 7:420 Page 6 of 9
http://www.parasitesandvectors.com/content/7/1/420globin gene fragments (268 bp) indicates that the DNA
sample is adequate for PCR analysis and that no PCR
inhibitors are present.
In our case 49/58 of samples were detected by at least
one PCR assay for Leishmania DNA (Table 3), it is sup-
posed there were no PCR inhibitors in these samples.
Nevertheless, for nine samples that were negative by the
three PCR assays we detected inhibition of the PCR in
only one sample when using the internal control: it
might well be due to the presence of a PCR inhibitor
that was not removed during the extraction method
process, or the degradation of the target DNA, or more
likely due to insufficient amount of biological material.
Unfortunately we could not repeat the tests for the cor-
responding patient.
Discussion
CL disease represents a major public health problem in
Morocco: in 2011, more than 4,000 cases were reported
[31]. According to the WHO, women and children are
the most affected groups; this fact was consistent with
our study where women were almost 4 times more af-
fected with CL than men (p = 0.036). They may be more
vulnerable because during the hot season they mostly
sleep indoors at night, while men sleep outside the
home. The Phlebotomus species in general and the fe-
male Phlebotomus in particular tended to be more endo-
philic than exophilic, although 40% of the Phlebotomus
females are collected outside [32].
The classical methods have limitations, especially with
regard to sensitivity ranging from 17 to 83% for DETable 5 Leishmania species identification
PCR assays L. major L. tropica Total
ITS1 PCR 19 25 44
L. tropica/L. infantum
Lmj4/Uni21 PCR 15 20 35
NB: one clinical sample identified as L. infantum by ITS1 PCR but negative by
the other techniques is not included in this table.[33-35], and from 27 to 85% for culture [18,34,35]. In
our study, 14 out of 23 samples positive by DE and/or
culture were detected by either of these methods
(Table 3), leading to low sensitivity values (Table 4).
This low performance of the parasitological diagnosis
might be due to the parasite load, the sampling site
(the more recent lesion is recommended in case of mul-
tiple lesions), or the evolution of skin lesions at the time of
the clinical examination (the number of the parasites in
skin lesions decreases in chronic CL). In our study, 38/58
samples (65%) were associated with long time evolution of
skin lesion before sampling, older than 4 months (Table 1,
Table 4). The responsible species is also involved especially
for cultures: L. infantum from dermal lesions is reported
to be more difficult to isolate [36]. Furthermore, the tech-
nical expertise of the biologist and the microbiological
contamination of the culture media can also impact nega-
tively on the sensitivity. For all these reasons the high
specificity of DE and culture is of little relevance especially
in endemic areas: indeed, a positive result with either of
these classical methods should always be considered a true
positive.
In our conditions, the 13A/13B primers showed higher
efficiency compared to the other primers, being able to
detect an equivalent of 0.1 promastigote cells per PCR
tube. This may be explained in part by the higher copy
number of the kDNA target (approximately 10,000 copies)
which is 50 and 250 fold higher than ITS1 target regions
(40 to 200 copies). Furthermore, the smaller size of the
13A/13B PCR products (120 bp) may be amplified more
efficiently than larger fragments (320 bp for ITS-1, and
650–850 bp for Lmj4/Uni21 primers). Lachaud et al. [37]
found a better value of 10−4 parasites per reaction with
13A/13B PCR but the Leishmania serial dilution assay
was performed by seeding the promastigotes into the buffy
coat [37]. Schönian et al. [26] showed that ITS1 PCR
could detect leishmanial DNA equivalent to 0.2 parasites
per PCR assay using filter paper spotted with peripheral
blood mixed with culture promastigotes [26]. Anders et al.
[25] reported that the Lmj4/Uni21 PCR could detect 0.25
parasites using pure DNA of promastigotes culture; how-
ever, they specified that these primers were often not sen-
sitive enough to detect a single parasite from clinical
samples [25]. Thus, the broad range of the reported detec-
tion rates can be explained by several parameters of which:
the kind of the clinical material, the DNA extraction
method that can affect the quality of DNA and the Taq
polymerase used as well [25]. Furthermore, we showed
that the results of the PCR assays are negatively correlated
with the time evolution of the cutaneous lesions.
In the present study and in order to enhance the spe-
cificity of our PCR assays, the samples were considered
molecular-positives when at least two PCR assays were
positive: 21 CL patients missed by both microscopic
Figure 2 2.5% Agarose gel electrophoresis of Lmj4/Uni21-PCR products. Wells: 1 – 11: patient samples; L. t: reference DNA of L. tropica;
L. i: reference DNA of L. infantum; L. m: reference DNA of L. major; NC: negative control sample (H2O); WM: Weight Marker (100 bp DNA
Ladder; Invitrogen Life Technologies, Brazil).
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least 2 PCRs (Table 3). These samples may have con-
tained very few parasites.
Both 13A/13B and ITS1 PCR assays gave sensitivities
of 100% based on our consensus positive, and 13A/13B
PCR identified four samples missed by the ITS1 PCR
(Table 3). Bensoussan et al. [21] reported sensitivities of
13A/13B and ITS1 PCR assays of 98.7% and 91% re-
spectively, while Azmi et al. [20] reported respective
sensitivities of 92% and 63.5%. These different rates for
the same primers can be explained by various factors
such as the length of infection affecting the parasite
loads, and also the different consensus standards consid-
ered in these studies.
Although the Lmj4/Uni21 primers amplifies a frag-
ment of a highly repetitive kDNA region, this PCR
showed the lowest sensitivity (Table 4); Anders et al.
[25] also considered this method limited in terms of
sensitivity (less than 10 parasites per tube). This can be
attributed in part to the larger size of the amplification
product (~650 - 800 bp), but also to the fact that Lmj4
primer was designed on the basis of a variable region
of the minicircle sequence. Only one study conducted
by Kumar et al. [22] reported that Lmj4/Uni21 PCR is
more sensitive than the ITS-1 but this result is based
on a smaller sample size (29 cases), and it may also
be due to the biopsy material used instead of lesion
aspiration [22].Table 6 Species characterization vs. known endemic focus
Origin of infe
L. tropica L. major L. tropica an
Species characterization L. tropica 13 2 0
L. major 3 13 1
Total 16 15 1
*According to the national data from the ministry of health.
NB: one clinical sample identified as L. infantum by ITS1 PCR but negative by the otFinally, in our conditions the kDNA 13A/13B PCR is a
highly sensitive diagnostic assay and thus seems a valu-
able tool for the diagnosis of CL, however, it is not able
to differentiate between the Leishmania species. The
Lmj4/Uni21 and ITS1 PCRs have the additional advan-
tage that the species can be distinguished. In our context
the species identification is not only important because
three species can be responsible for the disease, but also
for other purposes: a targeted therapy, and the study
of the epidemiology and dynamics of the disease. This
latter point is important to design well targeted con-
trol strategies. In the Moroccan frame, the existence
of three clinico-epidemiological forms of CL makes
clinical and epidemiological criteria alone definitely in-
adequate for species designation. As shown in Table 6,
six patient samples were characterized as L. tropica or
L. major while these species were not reported by the
Ministry of Health in the corresponding risk area, and
one patient from a CL free area was confirmed as a positive
CL case [31].
Concerning the ITS1 PCR, the restriction of the amp-
lification products of the three reference strains gave
three different patterns unambiguously differentiated
into L. tropica, L. infantum or L. major. All our dermal
samples ITS1 PCR positives displayed different restric-
tion patterns associated with L. tropica (25/45) or
L. major (19/45); one sample negative by the other PCR
assays was identified as L. infantum (Table 5). Given thatction (known foci of)* Total of true






7 2 1 25
1 1 0 19
8 3 1 44
her techniques is not included in this table.
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http://www.parasitesandvectors.com/content/7/1/420this parasite species has a viscerotropic potential, it re-
quires special monitoring even if it is not a confirmed
case by our consensus. Concerning the Uni21/Lmj4
PCR, this PCR method was not very sensitive and it
could not discriminate between L. tropica and L. infan-
tum infections. In Northern areas of Morocco where
both species may coexist, this primer is of little interest.
Conclusions
In conclusion, the PCR-based assays tested on our dermal
aspirates increased the speed and sensitivity of species-
specific leishmaniasis diagnosis compared to the conven-
tional techniques. In the Moroccan epidemiological
context, we showed that we cannot base the species
identification either on the clinical aspects of the skin le-
sions or on the data from the Ministry of Health. We
suggest the use of the ITS1 PCR-RFLP assay for diagnosis
and simultaneous identification of the species. The 13A/
13B PCR can be recommended in well-known foci and in
usual clinical presentations. However, PCR-based proto-
cols still need standardization and optimization; further-
more, the molecular approaches remain expensive and
require technological expertise especially for remote
areas where leishmaniasis is endemic. Thus, in the ab-
sence of PCR-based assays, we recommend that both
microscopic examination and parasite culture should be
employed together for CL diagnosis; negative samples
should be subjected to PCR diagnosis whenever possible
when they are associated with a suggestive clinical pres-
entation, or the possibility of infection with a viscero-
tropic species, and when other dermal pathologies have
been excluded.
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